Nano-based eye drop: Topical and noninvasive therapy for ocular diseases

Chuhan Wang; Yan Pang

doi:10.1016/j.addr.2023.114721

Nano-based eye drop: Topical and noninvasive therapy for ocular diseases

Adv Drug Deliv Rev. 2023 Mar:194:114721. doi: 10.1016/j.addr.2023.114721. Epub 2023 Feb 10.

Authors

Chuhan Wang¹, Yan Pang²

Affiliations

¹ Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.
² Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China. Electronic address: yanpang@sjtu.edu.cn.

PMID: 36773886
DOI: 10.1016/j.addr.2023.114721

Abstract

Eye drops are the most accessible therapy for ocular diseases, while inevitably suffering from their lower bioavailability which highly restricts the treatment efficacy. The introduction of nanotechnology has attracted considerable interest as it has advantages over conventional ones such as prolonged ocular surface retention time and enhanced ocular barrier penetrating properties, and achieving higher bioavailability and improved treatment efficacy. This review describes various ocular diseases treated with eye drops as well as the physiological and anatomical ocular barriers faced with through drug administration. It also summarizes the recent advances regarding the utilization of nanotechnology in developing eye drops, and how to optimize the nanocarrier-based ocular drug delivery systems. The prospective future research directions for nano-based eye drops are also discussed here.

Keywords: Eye drops; Nanoparticles; Nanotechnology; Non-invasive.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Biological Availability
Drug Delivery Systems
Eye
Eye Diseases* / drug therapy
Humans
Ophthalmic Solutions

Substances

Ophthalmic Solutions